Answers are grounded in this paper and cite their sources.
With the decline in incidence of severe disease due to group A β-hemolytic streptococci (CABHS) in developed countries over the past 4 decades most young clinicians have little experience with highly fatal diseases once associated with this organism. More recent reports, however, indicate that the epidemiology of GABHS disease has been changing over the past several years and severe disease is remerging. This review will focus on some of these changes and related developments; specifically, streptococcal pyoderma, streptococcal antigen detection kits, acute rheumatic fever and severe invasive streptococcal disease
No takes yet. Share an insight, caveat, or question.
Demers et al. (1993) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: